KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Treasury Shares (2016 - 2025)

Exact Sciences (EXAS) has disclosed Treasury Shares for 16 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Treasury Shares fell 48.16% to $1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 million, a 48.16% decrease, with the full-year FY2025 number at $1.0 million, down 48.16% from a year prior.
  • Treasury Shares was $1.0 million for Q4 2025 at Exact Sciences, down from $7.7 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $8.4 million in Q1 2025 to a low of $846058.0 in Q1 2021.
  • A 5-year average of $3.9 million and a median of $1.8 million in 2023 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: crashed 82.46% in 2021, then surged 614.0% in 2023.
  • Exact Sciences' Treasury Shares stood at $878114.0 in 2021, then increased by 10.22% to $967846.0 in 2022, then soared by 65.09% to $1.6 million in 2023, then increased by 26.5% to $2.0 million in 2024, then plummeted by 48.16% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Treasury Shares are $1.0 million (Q4 2025), $7.7 million (Q3 2025), and $8.1 million (Q2 2025).